AdvanSix (NYSE:ASIX – Get Free Report) announced its quarterly earnings data on Friday. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.37), FiscalAI reports. AdvanSix had a net margin of 0.67% and a return on equity of 2.18%. The firm had revenue of $421.28 million during the quarter, compared to analyst estimates of $452.00 million.
Here are the key takeaways from AdvanSix’s conference call:
- Second-quarter results improved sequentially but declined year over year: Sales rose 3% to $421 million, while adjusted EBITDA fell to $32 million and adjusted EPS declined to $0.19, primarily due to lower volumes and agricultural weakness.
- Strong commercial execution fully offset a $72 million year-over-year raw-material cost headwind, with pricing across Plant Nutrients, Chemical Intermediates, and Nylon Solutions recovering higher benzene, sulfur, and propylene costs.
- Plant Nutrients volumes were below expectations as elevated grower input costs and weak crop economics reduced fertilizer consumption; management expects a larger-than-usual sequential earnings headwind from the fall fertilizer reset due to high sulfur prices and channel inventory.
- Management expects significant second-half improvement in earnings and cash flow, supported by completed turnaround work, lower capital expenditures, working-capital tailwinds, cost reductions, and an anticipated $18 million Section 45Q tax-credit payment in the second half.
- AdvanSix is expanding optionality around its integrated ammonia platform, targeting a 30% increase in 2026 ammonia sales volume, pursuing a potentially 50%-funded USDA ammonia-capacity grant, and progressing its DEF project toward a 2027 investment decision.
AdvanSix Stock Performance
ASIX stock traded down $3.61 during trading on Friday, hitting $16.53. 718,970 shares of the company traded hands, compared to its average volume of 218,346. The stock’s 50-day simple moving average is $20.64 and its 200 day simple moving average is $20.79. The company has a debt-to-equity ratio of 0.34, a current ratio of 1.23 and a quick ratio of 0.68. The company has a market cap of $445.54 million, a PE ratio of 44.67 and a beta of 1.29. AdvanSix has a 1 year low of $14.10 and a 1 year high of $26.73.
AdvanSix Dividend Announcement
Analyst Upgrades and Downgrades
A number of brokerages recently commented on ASIX. Wall Street Zen lowered AdvanSix from a “hold” rating to a “sell” rating in a research report on Saturday. Zacks Research raised shares of AdvanSix to a “hold” rating in a report on Tuesday, May 12th. Finally, Weiss Ratings lowered shares of AdvanSix from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, May 13th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Reduce” and an average target price of $22.50.
Read Our Latest Stock Analysis on ASIX
Institutional Investors Weigh In On AdvanSix
Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in shares of AdvanSix by 0.5% during the 3rd quarter. Vanguard Group Inc. now owns 1,990,011 shares of the company’s stock valued at $38,566,000 after purchasing an additional 10,642 shares in the last quarter. Alliancebernstein L.P. lifted its stake in shares of AdvanSix by 55.3% in the 3rd quarter. Alliancebernstein L.P. now owns 948,491 shares of the company’s stock valued at $18,382,000 after purchasing an additional 337,908 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in AdvanSix by 23.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 711,634 shares of the company’s stock worth $12,311,000 after buying an additional 135,650 shares in the last quarter. Millennium Management LLC purchased a new stake in AdvanSix during the fourth quarter worth $11,479,000. Finally, Goldman Sachs Group Inc. grew its position in AdvanSix by 149.3% during the fourth quarter. Goldman Sachs Group Inc. now owns 378,610 shares of the company’s stock valued at $6,550,000 after buying an additional 226,756 shares during the period. Hedge funds and other institutional investors own 86.39% of the company’s stock.
AdvanSix News Summary
Here are the key news stories impacting AdvanSix this week:
- Positive Sentiment: AdvanSix declared a quarterly dividend of $0.16 per share, payable September 1 to shareholders of record August 18. The payout represents an annualized dividend of approximately $0.64 per share and a stated yield of about 3.9%, signaling that the company is maintaining shareholder distributions.
- Neutral Sentiment: The company’s Q2 2026 earnings presentation and conference-call transcript provide additional details on the quarter and management’s outlook, but the available reports do not identify a new catalyst strong enough to offset the earnings shortfall. AdvanSix Q2 2026 Results Earnings Call Presentation AdvanSix Q2 2026 Earnings Call Transcript
- Negative Sentiment: AdvanSix reported second-quarter earnings of $0.19 per share, well below the $0.56 consensus estimate. Revenue was $421.3 million, versus analyst expectations of $452 million, while the company posted a low 0.67% net margin and 2.18% return on equity. The earnings miss raises concerns about near-term demand, profitability and operating performance. AdvanSix Q2 Earnings Snapshot AdvanSix Posts Mixed Q2 Results
- Negative Sentiment: Wall Street Zen downgraded ASIX to “Sell,” adding further pressure after the disappointing quarterly results and reinforcing concerns about the stock’s earnings outlook. AdvanSix Cut to Sell at Wall Street Zen
AdvanSix Company Profile
AdvanSix, Inc (NYSE: ASIX) is an integrated chemical manufacturer specializing in the production of nylon 6 intermediates and related co‐products. Established as a publicly traded spin‐off from Honeywell Specialty Chemicals in June 2016, the company is headquartered in Parsippany, New Jersey.
The company’s principal product is caprolactam, the key building block for nylon 6 resin, used in fibers and engineering plastics across industries. In addition to caprolactam and nylon 6 resin, AdvanSix produces ammonium sulfate fertilizer and industrial chemicals such as phenol and acetone.
Read More
- Five stocks we like better than AdvanSix
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.
